Massachusetts remains a leader on the health care cost containment, price transparency, and market regulation fronts. In the 2017 legislative term, Massachusetts legislation aimed primarily at health insurance rate equity, pharmaceutical company drug development cost transparency, free access to the states ACPD, and hospital market regulation. Massachusetts introduced several bills that seek to improve transparency and health care costs; however, most of them failed to pass.
In this current legislative session, Massachusetts has carried over several bills that seek to improve transparency and health care cost.
The State Database
The Source tracks state activities impacting healthcare price and competition in both legislation and litigation in a searchable database to help stakeholders at the state level understand their legal and regulatory environment as they make efforts to improve access, quality, and efficiency, and reduce costs in healthcare. We currently cover bills from the 2017-2018 legislative term and key statutes from each state. Search the database for specific bills, statutes or cases by using keyword, key issue category, and/or jurisdiction.